Molecular determinants for the tissue specificity of SERMs
about
sameAs
Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonistsChanges in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and developmentTranscriptomic analyses of sexual dimorphism of the zebrafish liver and the effect of sex hormonesTranscriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylasesRBB, a novel transcription repressor, represses the transcription of HDM2 oncogeneProyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cellsThe catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcriptionSIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasmThe molecular mechanism governing the oncogenic potential of SOX2 in breast cancerZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylasesZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesisGAS, a new glutamate-rich protein, interacts differentially with SRCs and is involved in oestrogen receptor functionPKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1RAC3 is a pro-migratory co-activator of ERαProteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cellsCorepressors: custom tailoring and alterations while you wait.Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivatorDevelopmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activityMultiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibitionEstradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and betaPPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cellsEstrogen receptors and human diseaseScreening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic CohortDifferential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatmentPrenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.A conserved lysine in the estrogen receptor DNA binding domain regulates ligand activation profiles at AP-1 sites, possibly by controlling interactions with a modulating repressorAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyEndocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activityThe OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses.RNAi technology and its use in studying the function of nuclear receptors and coregulators.Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer MetastasisTherapeutic options for management of endometrial hyperplasiaPomegranate fruit as a rich source of biologically active compoundsCyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivoStructural insights into corepressor recognition by antagonist-bound estrogen receptorsThe 2.0 Å crystal structure of the ERα ligand-binding domain complexed with lasofoxifeneStructural plasticity in the oestrogen receptor ligand-binding domainLigand-binding dynamics rewire cellular signaling via estrogen receptor-α
P2860
Q21091197-B2734FE8-BD76-43EC-8D6C-7831704A87DCQ21131617-44D96845-BBDB-4048-9C24-81AFD2296A14Q21559705-F07BD544-6EF3-4F71-BE09-6DC42EDC3126Q24292875-79349B37-5C30-424B-A5B6-6BFEF66165AFQ24297569-313F2D56-EE36-4B91-98CF-1F88D1592BC9Q24299553-E49276AB-F7D3-469D-8ECE-6B4FABF14D5BQ24301763-2C708592-9E55-4727-94A7-E8E95E62273AQ24304823-67E20978-F3D4-4FDD-B35A-72D7C424E154Q24309520-B5B8C48D-F1BC-4305-AAF0-E29289458D92Q24312025-4DA398D6-7A27-4E41-B7B1-BD3005B74FEAQ24318720-57EA31CE-60CC-4159-B58F-F2415FE304EAQ24318938-7E71C518-4374-4012-BEFC-326E617981B8Q24318973-7E60AFBE-F946-4C3B-A0EE-E9E89A4C586AQ24336162-924483ED-8CEA-4985-A771-CAFCC173FD09Q24338281-63AEF269-0654-4A98-AFB2-A3438FC60319Q24540375-14487A5D-2C33-4AA1-BEB3-AA73ADB2053DQ24557088-B5796B09-B55A-4C31-9650-8A5A67975234Q24607485-47782696-CF05-4555-9DC1-35B571E6DC7CQ24613278-55D16006-99DB-482F-AAE9-1715BA54DCCBQ24632806-FFF615A2-7146-4DE7-8A32-C95979497790Q24633440-C8DA89CF-D409-4C3E-B5F8-7F95F9C6FCAEQ24641991-D5A565A6-3F61-4285-A9DA-5601A1C33C61Q24645374-60233453-C5C3-437E-AD3A-30F4C17FA0B1Q24656096-56F3D022-6521-46F2-826A-BBFB5CA79BC2Q24684364-D5043F5B-F9D8-498B-ABE2-4BA9FFFB6FBCQ24796687-B12D4A43-6566-4663-B326-83B7FB2E72AEQ24801123-CAFF7D89-93A0-445F-AF60-161951A3E742Q24803990-5D0F6413-E3DA-4F35-9521-A61BADC6ADB6Q24810287-F45E2019-DC4D-467B-B1AE-8F9B948800B4Q24815103-7E1B4C3D-AD71-445D-9A2B-D555A15FC6E3Q24816133-EF786BFB-D988-4953-AF16-04D207167853Q25255053-EAA24519-CE0C-4618-A67B-96DE2C9CE259Q26745561-C659CF9C-13DC-47D4-880E-5D05843928FEQ26783569-1C977855-1D7A-4E14-B30A-90AB0C860E0AQ26998985-A8432A06-39A2-43E8-9A40-2967A4BCBD06Q27302901-6556B7CB-3D0B-46F8-BAE5-8401A50A6CE4Q27643750-9A0628F8-319D-4D09-B7A4-726497176645Q27644597-74F47F98-D455-4D0D-A4CC-9B4CEB37A36EQ27644641-C4F7BAE2-D592-443C-9725-E5B99371AC57Q27677013-0F3AA807-68EF-48F6-822D-D812C4F29E7A
P2860
Molecular determinants for the tissue specificity of SERMs
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular determinants for the tissue specificity of SERMs
@ast
Molecular determinants for the tissue specificity of SERMs
@en
Molecular determinants for the tissue specificity of SERMs
@nl
type
label
Molecular determinants for the tissue specificity of SERMs
@ast
Molecular determinants for the tissue specificity of SERMs
@en
Molecular determinants for the tissue specificity of SERMs
@nl
prefLabel
Molecular determinants for the tissue specificity of SERMs
@ast
Molecular determinants for the tissue specificity of SERMs
@en
Molecular determinants for the tissue specificity of SERMs
@nl
P3181
P356
P1433
P1476
Molecular determinants for the tissue specificity of SERMs
@en
P2093
Yongfeng Shang
P304
P3181
P356
10.1126/SCIENCE.1068537
P407
P50
P577
2002-03-29T00:00:00Z